High-quality diagnostic kits, assays and research reagents

Cellbae Pte Ltd actively develops essential assays and reagents for the detection and surveillance of human and veterinary diseases, as well as food pathogens.

About Us

Cellbae Pte Ltd is an innovative in vitro diagnostic company headquartered in Singapore. It is a spin-off company from the Agency for Science, Technology and Research (A*STAR), Singapore. We are committed to improving lives through scientific discovery and technological innovation. Our current flagship product is the TEPAT 1.0 SARS-CoV-2 Multiplex RT-PCR KIT that employs multiplex RT-PCR technology to detect the presence of SARS-CoV-2 (COVID-19) with high accuracy. Cellbae also provides novel predictive toxicology assays for testing the safety of drugs, chemicals, food and consumer care products, and for environmental monitoring.


SaferWorldbyDesign Webinar by Dr. Daniele Zink

Accurate High-Throughput Prediction of Hepatocyte Toxicity in Humans

Tuesday, February 2, 2021, 14:00 CET



TEPAT 1.0 SARS-CoV-2 Multiplex RT-PCR kit

For the accurate detection of COVID-19. This kit has received Provisional Authorization for IVD use from the Health Sciences Authority (HSA) of Singapore.


Accurate Prediction of Human Organ Toxicity

  • Nephrotoxicity Prediction
  • Prediction of Hepatocyte Toxicity in Humans
  • Prediction of Vascular Endothelial Toxicity in Humans

Product Pipelines

Real Time RT-PCR Assays

Highly multiplexed PCR assays for various diseases.

Nanoprobe Assays

Highly sensitive and specific genotyping assays.

SeroFlow Rapid Test Kits

Rapid diagnostic test kits at the point-of-care.